Selected Infectious Diseases

  • Ginger S. Kubala
Chapter

Abstract

Selected nationally notifiable infectious diseases reported to the Centers for Disease Control (CDC) for 1994 include (1) Lyme disease, 13,043 reported cases; (2) Rocky Mountain spotted fever, 465 cases; (3) psittacosis, 38 cases; and (4) trichinosis, 32 cases.1 Toxoplasmosis and giardiasis are highly prevalent but are not considered notifiable to the CDC.

Keywords

Disseminate Intravascular Coagulation Lyme Disease Spotted Fever Congenital Toxoplasmosis Periorbital Edema 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Summary of notifiable diseases, United States—October 6. MMWR 1995;43:3–80.Google Scholar
  2. 2.
    St. Georgiev V. Management of toxoplasmosis: practical therapeutics. Drugs 1994;48:179–88.PubMedCrossRefGoogle Scholar
  3. 3.
    Holliman RE. Congenital toxoplasmosis: prevention, screening and treatment. J Hosp Infect 1995;30:179–90. [Volume 30 (Supplement)] PubMedCrossRefGoogle Scholar
  4. 4.
    Winstanley P. Drug treatment of toxoplasmic encephalitis in acquired immunodeficiency syndrome. Postgrad Med J 1995;71:404–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Roizen N, Swisher CN. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 1995; 95:11–20.PubMedGoogle Scholar
  6. 6.
    Nussenblatt RB, Belfort R. Ocular toxoplasmosis. JAMA 1994;271:304–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Behbahani R, Moshfeghi M. Therapeutic approaches for AIDS-related toxoplasmosis. Ann Pharmacother 1995;29: 760–8.PubMedGoogle Scholar
  8. 8.
    McCabe R, Chirurgi V. Issues in toxoplasmosis. Parasitic Dis 1993;7:587–603.Google Scholar
  9. 9.
    Matsui D. Prevention, diagnosis, and treatment of fetal toxoplasmosis. Clin Perinatol 1994;21:675–89.PubMedGoogle Scholar
  10. 10.
    Compton SJ, Celum CL. Trichinosis with ventilatory failure and persistent myocarditis. Clin Infect Dis 1993;16:500–4.PubMedCrossRefGoogle Scholar
  11. 11.
    MMWR. “Outbreak of trichinellosis associated with eating cougar jerky,” Idaho, 1995. 1996;45:205–6.Google Scholar
  12. 12.
    Mawhorter S, Kazura JW. Trichinosis of the central nervous system. Semin Neurol 1993;13:148–52.PubMedCrossRefGoogle Scholar
  13. 13.
    Stack P. Trichinosis, still a public health threat. Postgrad Med 1995;97:137–44.PubMedGoogle Scholar
  14. 14.
    Kirchner JT, Boyarsky SA. Chlamydia psittaci, an uncommon cause of community-acquired pneumonia. Arch Fam Med 1993;2:997–1001.PubMedCrossRefGoogle Scholar
  15. 15.
    Gherman RB, Leventis LL, Miller RC. Chlamydial psittacosis during pregnancy: a case report. Obstet Gynecol 1995; 86:648–50.PubMedCrossRefGoogle Scholar
  16. 16.
    Hughes P, Chidley K, Cowie J. Neurological complications in psittacosis: a case report and literature review. Respir Med 1995;89:637–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Schlossberg D, Delgado J, Moore M, et al. An epidemic of avian and human psittacosis. Arch Intern Med 1993;153: 2594–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Davies A, Collins T. Respiratory Chlamydia: the management of an outbreak. Public Health 1995;109:207–11.PubMedCrossRefGoogle Scholar
  19. 19.
    Farthing MJG. Diarrhoeal disease: current concepts and future challenges. Transact R Soc Trop Med Hyg 1993;87: 17–21.CrossRefGoogle Scholar
  20. 20.
    Lewis DIM, Freedman AR. Giardia lamblia as an intestinal pathogen. Dig Dis 1992;10:102–11.PubMedCrossRefGoogle Scholar
  21. 21.
    Babb RR. Giardiasis, taming this pervasive parasitic infection. Postgrad Med 1995;2:155–8.Google Scholar
  22. 22.
    Cook GC. Entamoeba histolytica and Giardia lamblia infections: current diagnostic strategies. Parasite 1995;2:107–12.PubMedGoogle Scholar
  23. 23.
    Gray SF, Gunnell DJ, Peters TJ. Risk factors for giardiasis: a case-control study in Avon and Somerset. Epidemiol Infect 1994;113:95–102.PubMedCrossRefGoogle Scholar
  24. 24.
    Hill DR. Giardiasis, issues in diagnosis and management. Parasitic Dis 1993;7:503–25.Google Scholar
  25. 25.
    Lyme Disease—United States 1994. MMWR 1995;44:459–62.Google Scholar
  26. 26.
    Evans J. Lyme disease. Curr Opin Rheumatol 1995;7:322–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Khorenian SD, Lebwohl M. New cutaneous manifestations of systemic diseases. Am Fam Physician 1995;51:625–30.PubMedGoogle Scholar
  28. 28.
    Pachner AR. Early disseminated Lyme disease: Lyme meningitis. Am J Med 1995;98:4A, 30S-43S.Google Scholar
  29. 29.
    Halperin JJ. Neuroborreliosis. Am J Med 1995;98:4A, 52S–62S.PubMedCrossRefGoogle Scholar
  30. 30.
    Sigal H. Early disseminated Lyme disease: cardiac manifestations. Am J Med 1995;98:4A, 25S-9S.Google Scholar
  31. 31.
    Oesch TR. Lyme borreliosis. J Tenn Med Assoc 1995;88: 131–3.PubMedGoogle Scholar
  32. 32.
    Steere AC. Musculoskeletal manifestations of Lyme disease. Am J Med 1995;98:4A, 44S-51S.Google Scholar
  33. 33.
    Ilowite N. Muscle, reticuloendothelial, and late skin manifestations of Lyme disease. Am J Med 1995;98:4A, 63S–8S.PubMedCrossRefGoogle Scholar
  34. 34.
    Magnarelli LA. Current status of laboratory diagnosis of Lyme disease. Am J Med 1995;98:4A, 10S-14S.PubMedCrossRefGoogle Scholar
  35. 35.
    Nowakowski J, Nadelman RB. Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans. J Am Acad Dermatol 1995;32:223–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Fish D. Environmental risk and prevention of Lyme disease. Am J Med 1995;98:4A, 2S-9S.PubMedCrossRefGoogle Scholar
  37. 37.
    Walker DH. Rickettsioses of the spotted fever group around the world. J Dermatol 1989;16:169–77.PubMedGoogle Scholar
  38. 38.
    Centers for Disease Control. RMSF-VS, 1990. MMWR 1991; 39:40.Google Scholar
  39. 39.
    Raoult D, Walker DH. Rickettsia rickettsii and other spotted fever group rickettsiae: principles and practice of infectious diseases. In Principles and Practice of Infectious Diseases, 3rd edit., edited by Mandell GL, Douglas RG, Jr., and Bennett JE. London: Churchill Livingstone, 1990, pp. 1465–71.Google Scholar
  40. 40.
    Kirk J, Fine DP, Sexton DJ, Muchmore HG. RMSF, a clinical review. Medicine 1990;69:35–45.PubMedCrossRefGoogle Scholar
  41. 41.
    Helmick CG, Bernard KW, D’Angelo LJ. RMSF: clinical laboratory and epidemiological features of 262 cases. J Infect Dis 1984;150:480–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Duffy RJ, Hammer ME. Ocular manifestations of RMSF. Ann Ophthalmol 1987;19:301–6.Google Scholar
  43. 43.
    Kamper CA, Chessman KH, Phelps SJ. RMSF, therapy review. Clin Pharmacol 1988;7:109–16.Google Scholar
  44. 44.
    Walker DH. RMSF: a disease in need of microbiological concern. Clin Microbiol Rev 1989;2:227–40.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Ginger S. Kubala

There are no affiliations available

Personalised recommendations